why choose us

First received: September 09, 2024

Clinical Trial: A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Respiratory Syncytial Virus

Study Type: INTERVENTIONAL


Official Title: A PHASE 3 STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN OLDER ADULTS IN KOREA

Brief Summary: The goal of this clinical trial is to quantify the immune response in older Korean adults after a RSVpreF vaccination.It will also learn about the safety and tolerability of RSVpreF vaccination.The main questions it aims to answer are:What local reactions and systemic events do participants have after a RSVpreF vaccination?What medical problems do participants have after a RSVpreF vaccination?Researchers will compare RSVpreF to a placebo (a look-alike substance that contains no RSVpreF) to see if RSVpreF is safe…

Read more